LOLotenna Olisaeloka

Lotenna Olisaeloka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lotenna Olisaeloka has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • COVID-19 and Excess Mortality in People with Mental Disorders: Lessons for Pandemic Preparedness

    by Lotenna Olisaeloka, Kristen L. Hudec, Angel Y. Wang, Richard J. Munthali, Lonna Munro, Joseph H. Puyat, Daniel V. Vigo

  • From Target to Trial: Artificial Intelligence in Psychiatric Drug Development

    by Lotenna Olisaeloka, John-Jose Nunez, Ram C. Shankaraiah, Raymond W. Lam, Daniel V. Vigo, Lakshmi N. Yatham

    Plain Language Summary: How Artificial Intelligence Could Improve Psychiatric Drug Development Developing new medicines for mental health conditions is difficult, expensive, and often unsuccessful. One reason is that people with the same diagnosis can differ greatly in their underlying biology and in how they respond to treatment. Clinical trials also rely heavily on symptom ratings and can be affected by placebo responses. This editorial explains how artificial intelligence (AI) could help at several stages of psychiatric drug development. AI can help researchers identify promising drug targets, design new treatment molecules, and use biological, brain-imaging, and clinical data to predict treatment response and improve clinical trials. Emerging approaches include digital twins, synthetic control groups, and digital measures of symptoms and behaviour. However, these technologies are still developing and should not be viewed as a solution to all the challenges of psychiatric drug development. Wider use will require representative datasets, strong data governance, transparent and interpretable models, rigorous clinical validation, and appropriate regulation.

  • Open Access

    AI-based detection of suicidal ideation in text: model development and evaluation for a student mental health chatbot

    by Lotenna Olisaeloka, Leonard Ruocco, Richard Munthali, Melissa Vereschaagin, Yuqian Zhuang, Angel Wang, Tiana Mori, Chris Richardson, Kristen Hudec, Daniel Vigo, et al.

    Background: Conversational digital mental health interventions (DMHIs) require mechanisms for recognizing expressions of suicidal ideation (SI) and initiating appropriate safety responses. Artificial intelligence (AI)-based detection approaches could provide a scalable safeguard; but systems designed for real world deployment must consider accuracy alongside computational efficiency, transparency, and appropriate response pathways. Methods: We developed a lightweight SI-detection system for integration into Minder, a mental health chatbot intervention for students. The detection pipeline combined a fine-tuned Sentence-BERT (SBERT) encoder with a nonparametric, anchor-based decision layer. The encoder was trained on 220,833 sentence-level text samples from public social media datasets. Fine-tuning used partial unfreezing and Batch-All Triplet Loss, with three configurations (Light, Medium, Heavy) compared on a development set. Each text input was encoded as 768-dimensional embeddings, then compared, using cosine similarity, against an expert-curated reference set of statements spanning suicidal ideation, intent, planning, and method. Inputs exceeding a development-set threshold were flagged as containing SI. The selected model was evaluated on a held-out test set and benchmarked against four open-weight generative language models under zero-shot prompting. Results: The Light fine-tuning configuration was selected for its strong performance and better preservation of the embedding space’s broader semantic structure. On the held-out test set, it achieved precision 0.91, recall 0.92, specificity 0.92, F1 0.91, and accuracy 0.92. A stricter threshold raised precision to 0.98 but lowered recall to 0.34. This trade-off informed a proposed workflow in which high-confidence detections trigger an immediate supportive response and crisis resources, while intermediate scores prompt clarification and re-evaluation. The system performed comparably to Phi-4 (accuracy 0.93, F1 0.92) while using roughly one-eighteenth of its storage and fewer than one-hundredth of its parameters. Conclusion: These findings demonstrate the technical feasibility of a computationally efficient, domain-grounded approach for SI detection in informal text. Keeping the decision logic separate from the encoder makes the system auditable and allows the flagging criteria to be inspected and iteratively refined. Prospective evaluation using contextually representative chatbot conversations is required before deployment, including assessment of missed disclosures, user acceptability, and clinical governance.

  • Open Access

    Generative AI Use for Mental Health Support: Patterns, Correlates, and Impact among Canadian Students

    by Lotenna Olisaeloka, Richard J Munthali, Daniel V Vigo

    Background. General purpose generative AI (GenAI) chatbots are increasingly used by students for mental health support. Research on prevalence estimates vary widely, rarely link use to validated clinical measures, and have not been reported in a Canadian student population. We estimated the prevalence trends, patterns, perceived impact, and correlates of GenAI use for mental health support among Canadian university students. Methods. We analysed one year (May 2025 to April 2026) repeated cross-sectional data from the Canadian arm of the WHO World Mental Health International College Student survey (WMH-ICS) The primary outcome was past-year prevalence of GenAI use for mental health support. Specific use purposes, perceived impact, reasons for non-use, and future use intent were also analysed. Factors associated with GenAI use were assessed using modified Poisson regression. As a sensitivity analysis, an elastic-net penalised regression model was fitted to assess the robustness of findings to an alternative modelling approach. Results. The past-year prevalence of GenAI chatbot use for mental health support was 25.2% (95% CI: 22.7 - 27.9), with a lifetime prevalence of 30.2%. Use was mostly occasional and predominately for seeking mental health information, stress management, and emotional support/companionship. Students of Asian ethnicity, those with higher clinical burden, recent adverse life experiences, weaker social support, and prior digital help-seeking behaviours were more likely to use GenAI for mental health purposes. Conversely, 2SLGBTQ+ students and those with romantic partners were less likely. Nearly three-quarters (74.2%) of users perceived such use to have a positive impact on their mental health and emotional wellbeing. Non-users reported preference for human interaction, distrust of GenAI in mental health (67.4% each), and privacy/security concerns (50.3%). Non-use also reflected principled objections to AI, including ethical and environmental concerns, with most non-users indicating no future use intention. Conclusions. GenAI chatbot use for mental health support has become commonplace among Canadian university students and is concentrated among those with greater mental health needs and fewer social support resources. Although most users perceived these tools as beneficial, their clinical effectiveness and safety remain uncertain. Rigorous prospective studies are needed to determine whether perceived benefits translate into improved mental health outcomes and whether purpose-built GenAI mental health interventions offer greater clinical benefit and safety than general-purpose chatbots.

  • Open Access

    Generative AI mental health chatbots: a scoping review of intervention design and user experience

    by Lotenna Olisaeloka, Chris G. Richardson, Angel Y. Wang, Richard J. Munthali, Daniel V. Vigo


  • Open Access

    Artificial intelligence (AI) psychosis: mechanisms, clinical risks and safety considerations in generative AI chatbots

    by Lotenna Olisaeloka, John-Jose Nunez, Daniel V. Vigo, Raymond Ng

    Summary: As generative artificial intelligence chatbots become embedded in everyday life, concerns about their psychological risks are growing. Emerging reports describe cases of artificial intelligence-induced or -associated psychosis (hereafter artificial intelligence (AI) psychosis) in which intensive chatbot use is associated with delusional thinking patterns. This paper proposes a provisional mechanism wherein baseline user vulnerabilities and engagement patterns interact with generative artificial intelligence characteristics, such as sycophancy and hallucination, contributing to delusional ideation. It subsequently outlines clinical, design and regulatory strategies that may help mitigate risks.


  • Top Cited Papers
    Open Access

    Safety Mechanisms and Risk Mitigation in Generative AI Mental Health Chatbots: A Systematic Scoping Review

    by Lotenna Olisaeloka, Chris G. Richardson, Angel Y. Wang, Richard J. Munthali, Daniel V. Vigo

    Background: Generative AI (GenAI) mental health chatbots are increasingly being developed to help address persistent barriers to mental healthcare. Unlike earlier rule-based and retrieval-based systems, GenAI chatbots generate open-ended outputs that can be inaccurate and unsafe. Documented harms from general-purpose GenAI chatbots have highlighted the need for purpose-built interventions with dedicated safeguards, yet how safety is implemented in such interventions remains poorly understood. Methods: This scoping review followed the Joanna Briggs Institute methodology and PRISMA-ScR guidelines, with a prospectively registered and peer-reviewed protocol. A systematic search of seven academic databases and search engines including MEDLINE, Scopus, PsycINFO, ACM Digital Library, IEEE Xplore, Google Scholar and Consensus was conducted in July 2025. Two reviewers independently screened records and extracted data. Safety mechanisms and risk mitigation strategies were narratively synthesised across three pre-specified domains: technical safeguards, pre-deployment safety considerations, and delivery-phase risk mitigation strategies. Results: Twenty-one studies across 11 countries were included. Most interventions incorporated at least one technical safety mechanism, most commonly fine-tuning and prompt engineering. A smaller subset implemented layered safety architectures combining retrieval systems, content filters or risk classifiers, and rule-based algorithms. Pre-deployment safeguards included clinical expert and user co-design approaches, research ethics procedures, and data privacy measures. During intervention delivery, detailed onboarding with role clarification was common, but human oversight was limited. Crisis referral protocols varied in rigour but were mostly underdeveloped, and systematic adverse event monitoring was sparse. Documented safety failures included missed suicidal ideation and provision of inaccurate clinical information. Conclusions: GenAI chatbot interventions require a robust sociotechnical approach that integrates technical safeguards with user co-design, procedural controls, and human oversight. Future research is needed to evaluate efficacy, improve safeguards and standardise safety outcome measurement. Regulatory oversight proportional to the risks these systems carry is required to enable integration into stepped or blended mental healthcare.


  • Open Access

    Safety Mechanisms and Risk Mitigation in Generative AI Mental Health Chatbots: A Systematic Scoping Review

    by Lotenna Olisaeloka, Chris Richardson, Angel Wang, Richard Munthali, Daniel Vigo

    Background: Generative AI (GenAI) mental health chatbots are increasingly being developed to help address persistent barriers to mental healthcare. Unlike earlier rule-based and retrieval-based systems, GenAI chatbots generate open-ended outputs that can be inaccurate and unsafe. Documented harms from general-purpose GenAI chatbots have highlighted the need for purpose-built interventions with dedicated safeguards, yet how safety is implemented in such interventions remains poorly understood. Methods: This scoping review followed the Joanna Briggs Institute methodology and PRISMA-ScR guidelines, with a prospectively registered and peer-reviewed protocol. A systematic search of seven academic databases and search engines including MEDLINE, Scopus, PsycINFO, ACM Digital Library, IEEE Xplore, Google Scholar and Consensus was conducted in July 2025. Two reviewers independently screened records and extracted data. Safety mechanisms and risk mitigation strategies were narratively synthesised across three pre-specified domains: technical safeguards, pre-deployment safety considerations, and delivery-phase risk mitigation strategies. Results: Twenty-one studies across 11 countries were included. Most interventions incorporated at least one technical safety mechanism, most commonly fine-tuning and prompt engineering. A smaller subset implemented layered safety architectures combining retrieval systems, content filters or risk classifiers, and rule-based algorithms. Pre-deployment safeguards included clinical expert and user co-design approaches, research ethics procedures, and data privacy measures. During intervention delivery, detailed onboarding with role clarification was common, but human oversight was limited. Crisis referral protocols varied in rigor but were mostly underdeveloped, and systematic adverse event monitoring was sparse. Documented safety failures included missed suicidal ideation and provision of inaccurate clinical information. Conclusion: GenAI chatbot interventions require a robust sociotechnical approach that integrates technical safeguards with user co-design, procedural controls, and human oversight. Future research is needed to evaluate efficacy, improve safeguards, and standardize safety outcome measurement. Regulatory oversight proportional to the risks these systems carry is required to enable integration into stepped or blended mental healthcare.

  • Open Access

    Generative AI Mental Health Chatbots: A Scoping Review of Intervention Design and User Experience

    by Lotenna Olisaeloka, Chris Richardson, Angel Wang, Richard Munthali, Daniel Vigo

    Generative AI (GenAI) mental health chatbots offer scalable, on-demand support with the potential to address persistent gaps in mental healthcare access. Yet evidence on how these interventions are designed and how users experience them remains fragmented. To our knowledge, this scoping review represents the first systematic and integrated mapping of conversational agent features, intervention design characteristics and user experience (UX) outcomes in purpose-built GenAI mental health chatbot interventions. A systematic search of seven databases identified 1899 articles, from which 21 studies across 11 countries were included. Most interventions were early-stage, cognitive behavioural therapy-based, and delivered through non-embodied text chatbots. Target conditions included depression, anxiety, dementia, eating disorders, and post-traumatic stress disorder. UX outcomes indicated moderate-to-high usability, therapeutic alliance, and user satisfaction, driven by convenience, personalisation, and perceived empathy. However, engagement commonly declined over time, attributed to limited interactivity, and erosion of trust following inaccurate or contextually misaligned outputs. Design approaches including multi-modal interaction, domain knowledge grounding, structured delivery formats, and co-design processes emerged as important influences on UX outcomes. Future work should prioritise efficacy trials that incorporate standardised UX outcome measures and researchers should adopt co-design approaches with diverse end-users to enable equitable, human-centred interventions.


  • Open Access

    AI Psychosis: Mechanisms, Clinical Risks, and Safety Considerations in Generative AI Chatbots

    by Lotenna Olisaeloka, John-Jose Nunez, Daniel Vigo, Raymond Ng

    As generative AI chatbots become embedded in everyday life, their inherent risks are manifesting in unprecedented ways. Emerging reports describe cases of AI Psychosis in which intensive chatbot use triggers delusional thinking and altered behaviour. This paper proposes a mechanism wherein baseline user vulnerabilities and specific engagement patterns interact with generative AI attributes, such as sycophancy and hallucination, to induce cognitive distortions. Subsequently, it outlines clinical, design, and regulatory strategies that can help mitigate risks.